ITEMS OF INTEREST TO THE IMAGING RESEARCH COMMUNITY:
CIP Web Site: http://www.cancer.gov/bip
- Third National Forum on Biomedical Imaging in Oncology,
January 31 - February 1, 2002
Location: Hyatt Arlington at Washington's Key Bridge, 1325 Wilson Boulevard, Arlington, Virginia 22209-9990 ;
Telephone: 703-525-1234; FAX: 703-525-1476
The aims are to 1) provide a forum for the exchange of information regarding the biomedical opportunities, challenges, and needs for imaging in oncology; 2) identify and begin to address industry considerations, e.g., scientific, technological, regulatory, and reimbursement; 3) facilitate the alignment of key biomedical opportunities with technology development activities
- REVISED POLICY ON THE ACCEPTANCE FOR REVIEW OF UNSOLICITED APPLICATIONS THAT REQUEST $500,000 OR MORE IN DIRECT COSTS (NOT-OD-02-004)
- CLINICAL CANCER THERAPY RESEARCH (NCI) (PA-02-002)
The National Cancer Institute (NCI) seeks grant applications to conduct clinical therapeutic studies/trials of neoplastic diseases in humans. Clinical research, by definition, is research conducted with human subjects (or on material of human origin such as tissues, specimens and cognitive phenomena) for which an investigator (or colleague) directly interacts with human subjects.
- NEUROIMAGING TECHNOLOGY DEVELOPMENT TO ASSESS BRAIN AND BEHAVIOR IN PEDIATRIC POPULATIONS (NIDA, NIDCD, NIBIB) (RFA-DA-02-001)
Letter of Intent Receipt Date: February 19, 2002
Application Receipt Date: March 19, 2002
The purpose of this RFA is to support studies that will address methodological and technical issues associated with the use of rapidly developing neuroimaging technology in assessing brain and behavioral development in child and adolescent populations, particularly those exposed to drugs of abuse or those with developmental or acquired communication disorders.
- MUSCULOSKELETAL DISORDERS: PREVENTION AND TREATMENT (NIOSH)(NIAMS) (RFA-OH-02-004)
Letter of Intent Receipt Date: December 4, 2001;
Application Receipt Date: January 15, 2002
This initiative marks the continued collaborative efforts of the National Institute of Occupational Safety and Health (NIOSH) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) to support research focused on the prevention and treatment of musculoskeletal disorders.
- BIOENGINEERING RESEARCH PARTNERSHIPS (PAR-02-010)
Notice of Intent Receipt Dates: December 21, 2001 and July 12, 2002
Application Receipt Dates: January 24, 2002 and August 12, 2002
Participating Institutes and Centers (ICs) of the National Institutes of Health invite applications for R01 awards to support Bioengineering Research Partnerships (BRPs) for basic and applied multi-disciplinary research that addresses important biological or medical research problems. A BRP is a multi- disciplinary research team applying an integrative, systems approach.
- BIOENGINEERING RESEARCH GRANTS (PA-02-011)
Participating Institutes and Centers (ICs) of the National Institutes of Health invite applications for R01 awards to support Bioengineering Research Grants (BRGs) for basic and applied multi-disciplinary research that addresses important biological or medical research problems. The BRGs support multi- disciplinary research performed in a single laboratory or by a small number of investigators.
- AVAILABILITY TO THE SCIENTIFIC COMMUNITY OF MICE WITH SELECTIVE MUTATIONS (NOT-MH-01-011)
- NONHUMAN PRIMATE MODELS OF NEUROBIOLOGICAL MECHANISMS OF ADOLESCENT ALCOHOL ABUSE AND ALCOHOLISM (NIAAA) (AA-02-006)
Letter of Intent Receipt Date: January 21, 2002;
Application Receipt Date: February 19, 2002
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) invites applications using nonhuman primate models to focus on the following areas: neurobiological mechanisms and risk factors for alcoholism during late childhood through adolescence; etc. It is the intent of this Request for Applications to foster interdisciplinary research (e.g., behavior, neuroanatomy, neurophysiology, neuropharmacology, neuroimaging). Therefore, good integration among components with diverse scientific disciplines is essential.
- MULTIMODAL INTEGRATION RESEARCH NETWORKS IN COGNITIVE NEUROSCIENCE (NINDS) (NS-02-011)
Letter of Intent Receipt Date: December 17, 2001;
Application Receipt Date: January 18, 2002
The National Institute of Neurological Disorders and Stroke (NINDS) invites grant applications for the formation of cross-disciplinary networks of scientists interested in studying the neural mechanisms of cognition and other complex behaviors.
- DEVELOPMENT OF PET AND SPECT LIGANDS FOR BRAIN IMAGING (PHASED INNOVATION AWARD) (NIMH) (NIDA) (NIA) (MH-02-003)
Letter of Intent Receipt Date: November 12, 2001;
Application Receipt Date: December 11, 2001
This solicitation invites applications for the development of novel radioligands for positron emission tomography (PET) and single photon emission computed tomography (SPECT) imaging in human brain, and that incorporate pilot or clinical feasibility evaluation in pre-clinical studies, model development, or clinical studies.
- INNOVATIVE PARTNERSHIPS IN TYPE 1 DIABETES RESEARCH (NIDDK PRIMARY)(DK-02-023)
Letter of Intent Receipt Date: February 14, 2002;
Application Receipt Date: March 14, 2002
The National Institute of Diabetes and Digestive and Kidney Diseases and other Institutes invite applications to support collaborations between investigators who focus their research efforts on type 1 diabetes or its complications and researchers from other research areas with expertise relevant to type 1 diabetes research.
- PILOT AND FEASIBILITY PROGRAM IN DIABETES ENDOCRINOLOGY AND METABOLISM (NIDDK) (PA-02-008)
The primary intent of this initiative is to foster the development of high-risk, high-impact pilot and feasibility research by established or newly independent investigators to develop new ideas sufficiently to allow for submission of a full R01 application for use on research problems relevant to the study of endocrine and metabolic diseases, especially diabetes and its complications.
- NSF BIOPHOTONICS PARTNERSHIP INITIATIVE III (BPIII) (NSF-02-012)
FULL PROPOSAL DEADLINE(S): February 25, 2002
The Division of Bioengineering and Environmental Systems (BES) of the National Science Foundation (NSF) announces the third in a series of Biophotonics Partnership initiatives seeking high risk/high return, multidisciplinary studies of novel concepts in biophotonics. Incremental advances of existing technologies will not be considered. NIH and DARPA will participate in the reviews and identify proposals of mutual interest and may provide co-funding for programs of high quality that meet their programatic and relevancy requirements.
- NSF MAJOR RESEARCH INSTRUMENTATION (MRI) PROGRAM
The Major Research Instrumentation Program (MRI) is designed to increase access to scientific and engineering equipment for research and research training in our Nation's academic institutions. This program seeks to improve the quality and expand the scope of research and research training in science and engineering, and to foster the integration of research and education by providing instrumentation for research-intensive learning environments.
- NSF QUANTUM AND BIOLOGICALLY INSPIRED COMPUTING (QuBIC)
The program will support interdisciplinary research to improve the fundamental capabilities of computer and information sciences and engineering by incorporating insights from either biological systems or quantum foundations or both.
- American Heart Association National Grant Programs Science Focus: Research broadly related to cardiovascular function and disease, stroke, or to related basic science, clinical, bioengineering/biotechnology, and public health problems.
Scientist Development Grant and Established Investigator Grant: January 14, 2002, July 15, 2002
Grant-in-Aid: January 15, 2002, July 16, 2002
National Fellow to Faculty Transition Award: January 14, 2002
- Doris Duke INNOVATION IN CLINICAL RESEARCH AWARD
Letters of Intent Due: November 28, 2001
Invitations to Submit Full Proposals Issued: February 12, 2002
Invited Proposals Due: March 26, 2002
The purpose of the Doris Duke Innovation in Clinical Research Award is to stimulate the development of novel approaches in cardiovascular disease including stroke, and sickle cell anemia and other blood disorders (excluding cancer). The award provides $100,000 per year for two years, with a possibility of renewal for a third year.
The Cancer Imaging Program at NCI has created this e-mail distribution list to notify interested people about funding opportunities and other issues related to imaging research. Its primary purpose is to call your attention to important, relevant information on NIH Web pages, or in the NIH Guide. Occasionally it may be used to clarify areas of confusion, or disseminate answers to frequently asked questions.
If you wish to remain on the list, no action is necessary. If you wish to be added to the list (or removed from it), please contact Ms. Johnnie Smith by return e-mail (email@example.com).
Cancer Imaging Program
Division of Cancer Treatment and Diagnosis, NCI
EPN, Room 6000 - MSC-7412
6130 Executive Boulevard
Bethesda, MD 20892-7440
Tel: 301 496 9531
Fax: 301 480 3507